Bemis Drug Co Inc
Community/Retail Pharmacy
6 Brighton St, Abington
Massachusetts, 02351-1738
781-878-0893 781-878-3101
Bemis Drug Co Inc is a Community/Retail Pharmacy in Abington, Massachusetts. It is located at 6 Brighton St, Abington and it's customer support contact number is 781-878-0893. The authorized person of Bemis Drug Co Inc is William Cox, BS who is Owner of the pharmacy and his contact number is 781-878-0893. Active license number of Bemis Drug Co Inc is DS1559 for Community/Retail Pharmacy in Massachusetts. Bemis Drug Co Inc accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance.
Bemis Drug Co Inc is a pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers (sometimes independent of the dispensing process); administer vaccinations; and provide other professional services associated with pharmaceutical care such as health screenings, consultative services with other health care providers, collaborative practice, disease state management, and education classes.
Pharmacy Details:
Bemis Drug Co Inc type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
| Name: | Bemis Drug Co Inc |
| Type: | Community/Retail Pharmacy |
| Location: | 6 Brighton St, Abington,
Massachusetts, 02351-1738 |
| Phone: | 781-878-0893 |
| Fax: | 781-878-3101 |
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
| Name: | William Cox |
| Credentials: | BS |
| Position: | Owner |
| Contact Number: | 781-878-0893 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
| NPI Number: | 1154336766 |
| NPI Enumeration Date: | 30 Jul, 2006 |
| NPI Last Update On: | 19 Sep, 2025 |
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Bemis Drug Co Inc are as mentioned below.
| Specialization | License Number | State | Status | |
| Community/Retail Pharmacy | DS1559 | Massachusetts | Primary | |
| Pharmacy | | | Secondary | |
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
| Identifier | Type | State | Issuer |
| 2039283 | Other | | Pk |
| 0499714 | Medicaid | Massachusetts | |
Medicare Enrollment:
Bemis Drug Co Inc is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
| PAC ID: |
Enrollment ID: |
Org Name | Medicare Entity Type |
| 9638296254 | O20100930075478 | Bemis Drug Co Inc | DME SUPPLIER - PHARMACY |
Products Available:
Bemis Drug Co Inc has following products available for sale under medicare.
| Products: |
|---|
| • Nebulizer Equipment & Supplies | |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | Po Box 187,
Abington, Massachusetts |
| Zip: | 02351-0187 |
| Phone Number: | 781-878-0893 |
| Fax Number: | 781-878-3101 |
Patients can reach Bemis Drug Co Inc at
6 Brighton St, Abington, Massachusetts or can
call on customer care at 781-878-0893.
Comments/ Reviews:
Read all the reviews posted for Bemis Drug Co Inc below. You may also share your own experience with Bemis Drug Co Inc. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.